Pay in 4 interest-free payments of $26.25 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6
CAS Number: 325457-99-6
It inhibited VEGFR-3 tyrosine kinase activity and VEGFR-3 autophosphorylation in HEK cells with IC(50) values of 20 and 45 nmol/L
Osteoarthritis Cartilage
29)/t22-/m0/s1
PF-04449913 0 Racemate Comprehensive evaluation of tamoxifen sequentialGlasdegib, also known as PF 04449913, is an orally bioavailable small molecule inhibitor of the Hedgehog (Hh) signaling pathway with potential antineoplastic activity. Hedgehog inhibitor PF 04449913 appears to inhibit Hh pathway signaling. The Hh signaling pathway plays an important role in cellular growth, differentiation and repair. Constitutive activation of Hh pathway signaling has been observed in various types of malignancies. Product
US$ 118.00
US$ 749.50
US$ 108.00
US$ 198.00
US$ 96.00